Status:

RECRUITING

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

Lead Sponsor:

Terns, Inc.

Conditions:

Chronic Myeloid Leukemia, Chronic Phase

Chronic Myeloid Leukemia

Eligibility:

All Genders

18+ years

Phase:

PHASE1

PHASE2

Brief Summary

The goal of the study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of TERN-701, a highly selective allosteric inhibitor of BCR-ABL1, in participants with pr...

Eligibility Criteria

Inclusion

  • Key
  • Male or female participants ≥ 18 years of age at the time of signing the informed consent
  • Have an ECOG performance status score of 0 to 2
  • Have an established cytopathologically confirmed diagnosis of BCR-ABL1 positive CML in Chronic Phase
  • Have received treatment with at least one prior TKI and have treatment failure, suboptimal response, or treatment intolerance
  • Prior treatment with asciminib is allowed
  • Adequate organ function, as assessed by local laboratory
  • Key

Exclusion

  • Systemic antineoplastic therapy (including prior TKIs, interferon-alfa, therapeutic antibodies, chemotherapy) or other experimental therapy 7 days before the first dose of TERN-701
  • Have completed previous anticancer therapy without resolution of all associated clinically significant toxicity (to ≤ Grade 2 or baseline)

Key Trial Info

Start Date :

March 26 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 31 2030

Estimated Enrollment :

180 Patients enrolled

Trial Details

Trial ID

NCT06163430

Start Date

March 26 2024

End Date

May 31 2030

Last Update

January 12 2026

Active Locations (54)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 14 (54 locations)

1

University of Alabama Medicine (UAB Medicine)

Birmingham, Alabama, United States, 35233

2

Banner MD Anderson Cancer Center

Gilbert, Arizona, United States, 85234

3

UC Irvine Health

Orange, California, United States, 92868

4

Rocky Mountain Cancer Centers, LLP

Lone Tree, Colorado, United States, 80303

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL) | DecenTrialz